These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 18289525

  • 1. Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems.
    De Bosscher K, Van Craenenbroeck K, Meijer OC, Haegeman G.
    Eur J Pharmacol; 2008 Apr 07; 583(2-3):290-302. PubMed ID: 18289525
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Understanding stress through the genome.
    Meijer OC.
    Stress; 2006 Jun 07; 9(2):61-7. PubMed ID: 16895830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M, Stahn C, Hommes DW, Buttgereit F.
    Steroids; 2008 Oct 07; 73(9-10):1025-9. PubMed ID: 18221974
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of the glucocorticoid receptor ligand binding domain.
    Bledsoe RK, Stewart EL, Pearce KH.
    Vitam Horm; 2004 Oct 07; 68():49-91. PubMed ID: 15193451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health.
    Derijk RH, van Leeuwen N, Klok MD, Zitman FG.
    Eur J Pharmacol; 2008 May 13; 585(2-3):492-501. PubMed ID: 18423443
    [Abstract] [Full Text] [Related]

  • 11. The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues.
    Rashid S, Lewis GF.
    Clin Biochem; 2005 May 13; 38(5):401-9. PubMed ID: 15820768
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of intracellular, membrane, and plasma binding sites for corticosterone in house sparrows.
    Breuner CW, Orchinik M.
    Gen Comp Endocrinol; 2009 Sep 01; 163(1-2):214-24. PubMed ID: 19236873
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals?
    Odermatt A, Gumy C.
    Biochem Pharmacol; 2008 Nov 15; 76(10):1184-93. PubMed ID: 18765234
    [Abstract] [Full Text] [Related]

  • 15. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
    Schäcke H, Rehwinkel H, Asadullah K, Cato AC.
    Exp Dermatol; 2006 Aug 15; 15(8):565-73. PubMed ID: 16842594
    [Abstract] [Full Text] [Related]

  • 16. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.
    Chebotaev D, Yemelyanov A, Budunova I.
    Mol Carcinog; 2007 Aug 15; 46(8):732-40. PubMed ID: 17538956
    [Abstract] [Full Text] [Related]

  • 17. Valine 571 functions as a regional organizer in programming the glucocorticoid receptor for differential binding of glucocorticoids and mineralocorticoids.
    Lind U, Greenidge P, Gustafsson JA, Wright AP, Carlstedt-Duke J.
    J Biol Chem; 1999 Jun 25; 274(26):18515-23. PubMed ID: 10373460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.